Add Yahoo as a preferred source to see more of our stories on Google. Jan 28 (Reuters) - India's Gland Pharma reported a nearly 28% jump in third-quarter profit on Wednesday, boosted by strong sales ...

Beginning in 2026, the ACC's Distinguished Award for International Service will be named in honor of Navin C. Nanda, MD, FACC, thanks to the support of the American Association of Cardiologists of ...

Dec 8 (Reuters) - Indian drugmaker Dr Reddy's (REDY.NS), opens new tab signed an exclusive licensing pact with Australia's Immutep (IMM.AX), opens new tab to develop and distribute the latter's cancer ...

Dr. Reddy’s Laboratories is paying $20 million upfront for the rights to Immutep’s phase 3-stage LAG-3 candidate in certain territories while leaving the Australian biotech with ownership in key ...

Here’s a trio for you: Taylor Swift’s record-shattering The Life Of A Showgirl; Bad Bunny’s culture-defining residency in Puerto Rico (and subsequent, idiot-bothering confirmation for the Super Bowl ...

The leadership change was made by Digital Domain's board of directors and key investors and follows the exit of former president and COO Lala Gavgavian. By Winston Cho Sudhir Reddy has been named the ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min AAR's $78M acquisition of HAECO ...

Including her favorite travel face masks and the capris she wore in London.

Dr. Reddy’s Laboratories remains a compelling buy due to underappreciated growth in biosimilars and GLP-1 segments, despite near-term headwinds. RDY's Q2 FY26 results showed modest revenue growth, ...

Monday - Friday, 11:00 - 12:00 SIN/HK | 0500 - 06:00 CET In this video Dr Reddy's CEO Erez Israeli says the pivot is already visible - India and Europe growth is now driven by innovation, consumer ...

Pull requests help you collaborate on code with other people. As pull requests are created, they’ll appear here in a searchable and filterable list. To get started, you should create a pull request.